Biodesix Inc. (BDSX) Misses Q3 EPS by 110c

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($1.16), $1.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $20.83 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Is the global equity rally broadening? UBS weighs in
• Kotak Upgrades Narayana Hrudayalaya Ltd (NARH:IN) to Buy (1)